Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac Hello friend AMERICAN WORKERS LOOKING FOR JOBS, In the article you read this time with the title Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac, we have prepared this article well for you to read and take information in it. hopefully the contents of the post Article bank, Article contracting, Article health, Article lecturer, Article manufacturing, Article marketing, Article property, Article public, Article teachers, Article telecommunications,what we write can you understand. okay, happy reading.

Judul : Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac
link : Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac

Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac

In PLOS One, a new paper on repugnance and risk perception:

When money talks: Judging risk and coercion in high-paying clinical trials
Christina Leuker ,Lasare Samartzidis,Ralph Hertwig,Timothy J. Pleskac
Published: January 31, 2020

Abstract
Millions of volunteers take part in clinical trials every year. This is unsurprising, given that clinical trials are often much more lucrative than other types of unskilled work. When clinical trials offer very high pay, however, some people consider them repugnant. To understand why, we asked 1,428 respondents to evaluate a hypothetical medical trial for a new Ebola vaccine offering three different payment amounts. Some respondents (27%) used very high pay (£10,000) as a cue to infer the potential risks the clinical trial posed. These respondents were also concerned that offering £10,000 was coercive— simply too profitable to pass up. Both perceived risk and coercion in high-paying clinical trials shape how people evaluate these trials. This result was robust within and between respondents. The link between risk and repugnance may generalize to other markets in which parties are partially remunerated for the risk they take and contributes to a more complete understanding of why some market transactions appear repugnant.

Such is the article Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac

That's an article Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac this time, hopefully it can benefit you all. well, see you in other article postings.

You are now reading the article Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac with the link address https://americanworkerslooking.blogspot.com/2020/03/repugnance-and-risk-perception-in-paid.html

Tweet

Subscribe to receive free email updates: